Effect of Lenograstim on the Cost of Autologous Bone Marrow Transplantation
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 7 (3) , 238-241
- https://doi.org/10.2165/00019053-199507030-00007
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationThe Lancet, 1994
- Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.1992
- Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.1991
- GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989
- Bone marrow transplantation in the treatment of patients with lymphoma.1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988